MTOR and cancer: In malignant tumors, aberrant activation of mTOR can lead to dysregulation of autophagy, which is closely linked to disruptions in tumor cell proliferation, invasion, migration, and interactions such as apoptosis and ferroptosis, ultimately accelerating GC progression (Niu et al., 2024).